Science Explorer Interactive view Map
Company · Beijing · China

Sinocelltech Group (China)

sinocelltech.comROR OpenAlex
Research works
23
▲ 609% vs 2013–17
Citations
232
9.9 per fractional work
Top-10% rate
33.6%
record average 16.5%
Open access
72%
world 28%

Not ranked overall: Sinocelltech Group (China) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.96× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.43× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 13.02× its world share, 2 worksImmunology and Micro…Pharmacology, Toxicology and Pharmaceutics: 1.47× its world share, 0 worksPharmacology, Toxico…Computer Science: 0.13× its world share, 0 worksComputer ScienceEnergy: 0.25× its world share, 0 worksEnergyEngineering: 0.41× its world share, 1 worksEngineeringEnvironmental Science: 0.59× its world share, 0 worksEnvironmental ScienceMedicine: 2.86× its world share, 9 worksMedicineVeterinary: 2.18× its world share, 0 worksVeterinaryBusiness, Management and Accounting: 0.08× its world share, 0 worksBusiness, Management…Economics, Econometrics and Finance: 0.03× its world share, 0 worksEconomics, Econometr…Social Sciences: 0.22× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 13.0×. Every wedge is a field page.

Which keywords describe research at Sinocelltech Group (China)?

By fractional works in all years, weighted toward what it does more of than the world: SARS-CoV-2, Immunity, Pandemic, Vaccine, ACE2 Receptor, Coronavirus, antibody and spike protein.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 30 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 30 words, with their numbers
  1. SARS-CoV-25▲ 150×4 topics
  2. Immunity5▲ 58×4 topics
  3. Pandemic4▲ 43×3 topics
  4. Vaccine4▲ 48×5 topics
  5. ACE2 Receptor4▲ 163×2 topics
  6. Coronavirus4▲ 143×2 topics
  7. Epidemiology4▲ 4.0×10 topics
  8. antibody3▲ 310×1 topic
  9. spike protein3▲ 310×1 topic
  10. Immune Response2▲ 16×4 topics
  11. Antigen Presentation2▲ 88×2 topics
  12. Monoclonal Antibodies2▲ 62×3 topics
  13. Therapeutic Antibodies2▲ 53×2 topics
  14. Pathogenesis1▲ 10×5 topics
  15. Cancer Immunotherapy1▲ 41×2 topics
  16. Glycosylation1▲ 24×2 topics
  17. Innate Immunity1▲ 16×2 topics
  18. Thrombosis1▲ 26×3 topics
  19. Clinical Characteristics1▲ 77×1 topic
  20. Cytokine Storm1▲ 113×1 topic
  21. Reconstruction1▲ 26×2 topics
  22. Antibody Engineering1▲ 49×1 topic
  23. Dendritic Cells1▲ 42×1 topic
  24. Fc Receptors1▲ 49×1 topic
  25. Metagenomics1▲ 39×2 topics
  26. Numerical Simulation1▲ 14×3 topics
  27. Risk Assessment1▲ 7.8×3 topics
  28. Tumor Antigen1▲ 60×1 topic
  29. Archaeological Artifacts1▲ 166×1 topic
  30. Fragmented Objects1▲ 166×1 topic

Which research topics does Sinocelltech Group (China) publish most on?

By volume in 2022–2025: SARS-CoV-2 and COVID-19 Research, Immunotherapy and Immune Responses, COVID-19 Clinical Research Studies and vaccines and immunoinformatics approaches.

SARS-CoV-2 and COVID-19 …3SARS-CoV-2 and COVID-19 Research: 3 fractional worksImmunotherapy and Immune…1Immunotherapy and Immune Responses: 1 fractional worksCOVID-19 Clinical Resear…1COVID-19 Clinical Research Studies: 1 fractional worksvaccines and immunoinformatics approaches: 1 fractional worksMonoclonal and Polyclonal Antibodies Research: 1 fractional worksAnimal Virus Infections …1Animal Virus Infections Studies: 1 fractional worksCervical Cancer and HPV Research: 1 fractional worksVaccine Coverage and Hesitancy: 0 fractional worksRNA Interference and Gene Delivery: 0 fractional worksBacteriophages and microbial interactions: 0 fractional works
Infectious DiseasesImmunologyMolecular BiologyRadiology, Nuclear Medicine and Imaging4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 SARS-CoV-2 and COVID-19 Research Infectious Diseases 3 works
  2. 2 Immunotherapy and Immune Responses Immunology 1 works
  3. 3 COVID-19 Clinical Research Studies Infectious Diseases 1 works
  4. 4 vaccines and immunoinformatics approaches Molecular Biology 1 works
  5. 5 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  6. 6 Animal Virus Infections Studies Animal Science and Zoology 1 works
  7. 7 Cervical Cancer and HPV Research Epidemiology 1 works
  8. 8 Vaccine Coverage and Hesitancy Health 0 works
  9. 9 RNA Interference and Gene Delivery Molecular Biology 0 works
  10. 10 Bacteriophages and microbial interactions Ecology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available71.5%not open28.5%

World: 28% of research is openly available.

with international co-authors18.3%domestic only81.7%

World: 19% is written across borders.

How has Sinocelltech Group (China)'s research output changed?

Output in 2018–2022 was 609% higher than in 2013–2017.

201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Beijing

All research institutions in Beijing

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.